8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Apr 29, 2026·SEC
Material company update
Mar 12, 2026·SEC
Insulet Corporation(PODD)Earnings, Financials & Key Ratios
PODD•NASDAQ
41.9× P/E·Price updated Jun 19, 2026
AboutInsulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.Show more
- Revenue$2.71B+30.7%
- EBITDA$587M+50.6%
- Net Income$247M-40.9%
- EPS (Diluted)3.48-39.8%
- Gross Margin71.63%+2.6%
- EBITDA Margin21.67%+15.2%
- Operating Margin17.5%+17.3%
- Net Margin9.12%-54.8%
- ROE18.12%-57.9%
PODD Key Insights
Insulet Corporation (PODD) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 31.8%
- ✓Strong 5Y profit CAGR of 105.2%
- ✓Strong Piotroski F-Score: 7/9
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 24.5%
- ✓Share count reduced 2.7% through buybacks
✗Weaknesses
- ✗Weak momentum: RS Rating 9 (bottom 9%)
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when PODD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
PODD Price & Volume
Insulet Corporation (PODD) stock price & volume — 10-year historical chart
Loading chart...
PODD Growth Metrics
Insulet Corporation (PODD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years26.22%
5 Years24.53%
3 Years27.54%
TTM31.93%
Profit CAGR
10 Years-
5 Years105.15%
3 Years277.32%
TTM-24.71%
EPS CAGR
10 Years-
5 Years103.38%
3 Years275.36%
TTM-22.66%
Return on Capital
10 Years6.02%
5 Years10.41%
3 Years14.26%
Last Year18.69%
PODD Recent Earnings
Insulet Corporation (PODD) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$1.42+19.3%
$1.19
Rev
$762M+4.4%
$730M
Q1 2026
Feb 18, 2026Metric
Actual
Est
EPS
$1.55+5.4%
$1.47
Rev
$784M+1.9%
$769M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$1.24+8.8%
$1.14
Rev
$706M+4.1%
$678M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$1.17+27.2%
$0.92
Rev
$649M+5.7%
$614M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $1.42vs $1.19+19.3% | $762Mvs $730M+4.4% |
| Q1 2026 | Feb 18, 2026 | $1.55vs $1.47+5.4% | $784Mvs $769M+1.9% |
| Q4 2025 | Nov 6, 2025 | $1.24vs $1.14+8.8% | $706Mvs $678M+4.1% |
| Q3 2025 | Aug 7, 2025 | $1.17vs $0.92+27.2% | $649Mvs $614M+5.7% |
Based on last 12 quarters of dataView full earnings history →
PODD Peer Comparison
Insulet Corporation (PODD) competitors in Diabetes care and insulin delivery — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 DXCM | 27.96B | 72.47 | 34.67 | 15.6% | 19.31% | 33.83% | 0.51 | |
 TNDM | 1.05B | 15.30 | -5.03 | 7.93% | -9.2% | -68.29% | 2.86 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 ITGR | 3.13B | 90.96 | 31.47 | 7.57% | 7.67% | 8.23% | 0.80 | |
 ABT | 153.68B | 88.38 | 11.57 | 4.59% | 31.88% | 27.26% | 0.32 | |
 MDT | 101.86B | 79.34 | 21.98 | 3.62% | 13% | 9.49% | 0.59 | |
 BDX | 52.16B | 143.98 | 24.70 | 8.23% | 5.33% | 4.54% | 0.76 | |
 NVO | 191.93B | 43.19 | 12.18 | 6.43% | 37.2% | 66.36% | 0.67 |
Compare PODD vs Peers
Insulet Corporation (PODD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PODD Income Statement
Insulet Corporation (PODD) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 463.77M | 563.82M | 738.2M | 904.4M | 1.1B | 1.31B | 1.7B | 2.07B | 2.71B | 2.9B |
Revenue Growth % | 26.37% | 21.57% | 30.93% | 22.51% | 21.49% | 18.79% | 30.02% | 22.07% | 30.73% | 31.93% |
Cost of Goods Sold | 186.6M | 193.66M | 257.9M | 322.1M | 346.7M | 499.7M | 537.2M | 625.9M | 768.2M | 840.9M |
COGS % of Revenue | 40.24% | 34.35% | 34.94% | 35.61% | 31.55% | 38.28% | 31.65% | 30.21% | 28.37% | - |
Gross Profit | 277.17M▲ 0% | 370.17M▲ 33.6% | 480.3M▲ 29.8% | 582.3M▲ 21.2% | 752.1M▲ 29.2% | 805.6M▲ 7.1% | 1.16B▲ 44.0% | 1.45B▲ 24.6% | 1.94B▲ 34.2% | 2.06B▲ 0% |
Gross Margin % | 59.76% | 65.65% | 65.06% | 64.39% | 68.45% | 61.72% | 68.35% | 69.79% | 71.63% | 71.01% |
Gross Profit Growth % | 31.31% | 33.55% | 29.75% | 21.24% | 29.16% | 7.11% | 43.98% | 24.64% | 34.18% | - |
Operating Expenses | 284.6M | 342.8M | 430.3M | 530.8M | 626.1M | 768M | 939.9M | 1.14B | 1.47B | 1.55B |
OpEx % of Revenue | 61.37% | 60.8% | 58.29% | 58.69% | 56.98% | 58.84% | 55.38% | 54.88% | 54.14% | - |
Selling, General & Admin | 208.9M | 248M | 298M | 384M | 466M | 587.8M | 734.9M | 917.2M | 1.17B | 1.22B |
SG&A % of Revenue | 45.04% | 43.99% | 40.37% | 42.46% | 42.41% | 45.03% | 43.3% | 44.27% | 43.02% | - |
Research & Development | 74.45M | 88.61M | 132.3M | 146.8M | 160.1M | 180.2M | 205M | 219.6M | 301.1M | 331.2M |
R&D % of Revenue | 16.05% | 15.72% | 17.92% | 16.23% | 14.57% | 13.81% | 12.08% | 10.6% | 11.12% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -7.4M▲ 0% | 27.4M▲ 470.3% | 50M▲ 82.5% | 51.5M▲ 3.0% | 126M▲ 144.7% | 37.6M▼ 70.2% | 220M▲ 485.1% | 308.9M▲ 40.4% | 473.8M▲ 53.4% | 507.2M▲ 0% |
Operating Margin % | -1.6% | 4.86% | 6.77% | 5.69% | 11.47% | 2.88% | 12.96% | 14.91% | 17.5% | 17.48% |
Operating Income Growth % | 30.87% | 470.27% | 82.48% | 3% | 144.66% | -70.16% | 485.11% | 40.41% | 53.38% | - |
EBITDA | 6.5M | 43M | 77.9M | 106.9M | 183.4M | 100.8M | 292.8M | 389.7M | 586.9M | 582.1M |
EBITDA Margin % | 1.4% | 7.63% | 10.55% | 11.82% | 16.69% | 7.72% | 17.25% | 18.81% | 21.67% | 20.07% |
EBITDA Growth % | 107.73% | 561.54% | 81.16% | 37.23% | 71.56% | -45.04% | 190.48% | 33.09% | 50.6% | 37.16% |
D&A (Non-Cash Add-back) | 13.9M | 15.6M | 27.9M | 55.4M | 57.4M | 63.2M | 72.8M | 80.8M | 113.1M | 74.9M |
EBIT | -7.5M | 31.5M | 46.3M | 54.9M | 82.2M | 45.8M | 250.8M | 342.9M | 473.8M | 454.8M |
Net Interest Income | -18.6M | -21.3M | -34.6M | -45.1M | -61.2M | -26.7M | -7.6M | -3.2M | -45M | -20.6M |
Interest Income | 2.63M | 6.71M | 0 | 3M | 500K | 9.3M | 28.6M | 39.5M | 34.7M | 24.4M |
Interest Expense | 19.19M | 22.2M | 34.6M | 48.1M | 61.7M | 36M | 36.2M | 42.7M | 79.7M | 45M |
Other Income/Expense | -19.2M | -22.2M | -35.5M | -41.8M | -105.5M | -27.8M | -5.4M | -8.7M | -134.3M | -102.8M |
Pretax Income | -26.6M▲ 0% | 5.2M▲ 119.5% | 14.5M▲ 178.8% | 9.7M▼ 33.1% | 20.5M▲ 111.3% | 9.8M▼ 52.2% | 214.6M▲ 2089.8% | 300.2M▲ 39.9% | 339.5M▲ 13.1% | 404.4M▲ 0% |
Pretax Margin % | -5.74% | 0.92% | 1.96% | 1.07% | 1.87% | 0.75% | 12.65% | 14.49% | 12.54% | 13.94% |
Income Tax | 200K | 1.9M | 2.9M | 2.9M | 3.7M | 5.2M | 8.3M | -118.1M | 92.4M | 57.7M |
Effective Tax Rate % | -0.75% | 36.54% | 20% | 29.9% | 18.05% | 53.06% | 3.87% | -39.34% | 27.22% | 14.27% |
Net Income | -26.83M▲ 0% | 3.29M▲ 112.3% | 11.6M▲ 252.4% | 6.8M▼ 41.4% | 16.8M▲ 147.1% | 4.6M▼ 72.6% | 206.3M▲ 4384.8% | 418.3M▲ 102.8% | 247.1M▼ 40.9% | 302.8M▲ 0% |
Net Margin % | -5.79% | 0.58% | 1.57% | 0.75% | 1.53% | 0.35% | 12.16% | 20.19% | 9.12% | 10.44% |
Net Income Growth % | 7.09% | 112.27% | 252.37% | -41.38% | 147.06% | -72.62% | 4384.78% | 102.76% | -40.93% | -24.71% |
Net Income (Continuing) | -26.8M | 3.3M | 11.6M | 6.8M | 16.8M | 4.6M | 206.3M | 418.3M | 247.1M | 302.8M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.46▲ 0% | 0.05▲ 111.7% | 0.19▲ 251.9% | 0.10▼ 47.4% | 0.25▲ 150.0% | 0.07▼ 73.7% | 2.94▲ 4368.1% | 5.78▲ 96.6% | 3.48▼ 39.8% | 4.31▲ 0% |
EPS Growth % | 8% | 111.74% | 251.85% | -47.37% | 150% | -73.68% | 4368.09% | 96.6% | -39.79% | -22.66% |
EPS (Basic) | -0.46 | 0.06 | 0.19 | 0.11 | 0.25 | 0.07 | 2.96 | 5.97 | 3.51 | - |
Diluted Shares Outstanding | 58M | 61.01M | 62.3M | 65.95M | 68.58M | 69.91M | 73.63M | 73.89M | 71.89M | 70.2M |
Basic Shares Outstanding | 58M | 58.86M | 60.59M | 64.73M | 67.7M | 69.38M | 69.75M | 70.08M | 70.35M | 69.99M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
PODD Balance Sheet
Insulet Corporation (PODD) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 537.17M | 454.01M | 581.5M | 1.24B | 1.32B | 1.3B | 1.57B | 1.87B | 1.89B | 1.71B |
Cash & Short-Term Investments | 440.06M | 288.95M | 376.1M | 947.6M | 791.6M | 674.7M | 704.2M | 953.4M | 716.1M | 480.4M |
Cash Only | 272.58M | 113.91M | 203.7M | 907.2M | 791.6M | 623.9M | 650.7M | 953.4M | 716.1M | 480.4M |
Short-Term Investments | 167.48M | 175.04M | 172.4M | 40.4M | 0 | 50.8M | 53.5M | 0 | 0 | 0 |
Accounts Receivable | 53.37M | 76.67M | 82.8M | 83.8M | 161M | 205.6M | 359.7M | 365.5M | 516.9M | 544.7M |
Days Sales Outstanding | 42.01 | 49.63 | 40.94 | 33.82 | 53.48 | 57.49 | 77.36 | 64.4 | 69.67 | 61.91 |
Inventory | 33.79M | 71.41M | 101M | 154.3M | 303.2M | 346.8M | 402.6M | 430.4M | 452.6M | 462.5M |
Days Inventory Outstanding | 66.1 | 134.6 | 142.94 | 174.85 | 319.2 | 253.32 | 273.55 | 250.99 | 215.05 | 196.23 |
Other Current Assets | 9.95M | 16.98M | 21.6M | 52M | 60.7M | 71.7M | 99.8M | 121.9M | 203.1M | 221.9M |
Total Non-Current Assets | 279.57M | 474.74M | 561.4M | 635.2M | 732.3M | 952.3M | 1.02B | 1.22B | 1.3B | 1.28B |
Property, Plant & Equipment | 107.86M | 258.38M | 415.5M | 493.6M | 546.4M | 625.9M | 692.8M | 759.8M | 863.2M | 830.4M |
Fixed Asset Turnover | 4.30x | 2.18x | 1.78x | 1.83x | 2.01x | 2.09x | 2.45x | 2.73x | 3.14x | 3.70x |
Goodwill | 39.84M | 39.65M | 39.8M | 39.8M | 39.8M | 51.7M | 51.7M | 51.5M | 51.6M | 51.6M |
Intangible Assets | 4.35M | 10.38M | 13.2M | 28.7M | 36.6M | 75.5M | 98.7M | 98.5M | 117.1M | 115.2M |
Long-Term Investments | 125.55M | 140.78M | 58.4M | 14.8M | 19.3M | 15M | 0 | 5.5M | 20.1M | 58.3M |
Other Non-Current Assets | 1.97M | 25.54M | 34.5M | 58.3M | 90.2M | 184.2M | 178.7M | 159.4M | 167.3M | 280.5M |
Total Assets | 816.74M▲ 0% | 928.74M▲ 13.7% | 1.14B▲ 23.1% | 1.87B▲ 63.9% | 2.05B▲ 9.4% | 2.25B▲ 9.9% | 2.59B▲ 15.0% | 3.09B▲ 19.3% | 3.19B▲ 3.3% | 2.99B▲ 0% |
Asset Turnover | 0.57x | 0.61x | 0.65x | 0.48x | 0.54x | 0.58x | 0.66x | 0.67x | 0.85x | 0.92x |
Asset Growth % | 78.86% | 13.71% | 23.06% | 63.87% | 9.39% | 9.87% | 14.97% | 19.3% | 3.33% | 8.78% |
Total Current Liabilities | 86.03M | 115.66M | 157.7M | 207.8M | 228.8M | 364.7M | 451.2M | 528.4M | 680.1M | 687.5M |
Accounts Payable | 24.41M | 25.5M | 54.5M | 54.1M | 37.7M | 30.8M | 19.2M | 19.8M | 75M | 149.8M |
Days Payables Outstanding | 47.75 | 48.06 | 77.13 | 61.31 | 39.69 | 22.5 | 13.05 | 11.55 | 35.64 | 40.05 |
Short-Term Debt | 0 | 0 | 3.6M | 20.5M | 30.1M | 31.1M | 52.9M | 85.9M | 22.2M | 18.6M |
Deferred Revenue (Current) | 2.36M | 1.18M | 3.2M | 5.4M | 3.5M | 16.1M | 15.4M | 12M | 14M | 47.9M |
Other Current Liabilities | 24.31M | 51.15M | 50.6M | 74.7M | 87.2M | 190.8M | 241.7M | 267.9M | 359.7M | 519.1M |
Current Ratio | 6.24x | 3.93x | 3.69x | 5.96x | 5.75x | 3.56x | 3.47x | 3.54x | 2.78x | 2.49x |
Quick Ratio | 5.85x | 3.31x | 3.05x | 5.21x | 4.43x | 2.61x | 2.58x | 2.73x | 2.11x | 1.81x |
Cash Conversion Cycle | 60.35 | 136.17 | 106.75 | 147.37 | 333 | 288.31 | 337.86 | 303.84 | 249.08 | 218.09 |
Total Non-Current Liabilities | 572.2M | 600.99M | 909.3M | 1.06B | 1.26B | 1.41B | 1.4B | 1.35B | 995.1M | 997.1M |
Long-Term Debt | 566.17M | 591.98M | 887.9M | 1.04B | 1.25B | 1.37B | 1.37B | 1.3B | 979.7M | 0 |
Capital Lease Obligations | 0 | 0 | 14.4M | 12M | 7.6M | 27.4M | 29.5M | 40M | 48.9M | 48.9M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 5.13M | 8.11M | 6M | 4.8M | 5.8M | 6.7M | 6.5M | 9.6M | -35M | 997.1M |
Total Liabilities | 658.23M | 716.64M | 1.07B | 1.27B | 1.49B | 1.77B | 1.86B | 1.88B | 1.68B | 1.68B |
Total Debt | 566.17M | 591.98M | 905.9M | 1.08B | 1.29B | 1.43B | 1.45B | 1.42B | 1.05B | 18.6M |
Net Debt | 293.6M | 478.07M | 702.2M | 169M | 494.9M | 808.9M | 798.1M | 468.6M | 334.7M | -461.8M |
Debt / Equity | 3.57x | 2.79x | 11.94x | 1.78x | 2.31x | 3.01x | 1.98x | 1.17x | 0.69x | 0.01x |
Debt / EBITDA | 87.10x | 13.77x | 11.63x | 10.07x | 7.01x | 14.21x | 4.95x | 3.65x | 1.79x | 0.03x |
Net Debt / EBITDA | 45.17x | 11.12x | 9.01x | 1.58x | 2.70x | 8.02x | 2.73x | 1.20x | 0.57x | -0.79x |
Interest Coverage | -0.39x | 1.42x | 1.34x | 1.14x | 1.33x | 1.27x | 6.93x | 8.03x | 5.94x | 10.11x |
Total Equity | 158.52M▲ 0% | 212.1M▲ 33.8% | 75.9M▼ 64.2% | 603.6M▲ 695.3% | 556.3M▼ 7.8% | 476.4M▼ 14.4% | 732.7M▲ 53.8% | 1.21B▲ 65.4% | 1.52B▲ 25.1% | 1.3B▲ 0% |
Equity Growth % | 151.02% | 33.8% | -64.21% | 695.26% | -7.84% | -14.36% | 53.8% | 65.36% | 25.06% | 93.27% |
Book Value per Share | 2.73 | 3.48 | 1.22 | 9.15 | 8.11 | 6.81 | 9.95 | 16.40 | 21.08 | 18.56 |
Total Shareholders' Equity | 158.52M | 212.1M | 75.9M | 603.6M | 556.3M | 476.4M | 732.7M | 1.21B | 1.52B | 1.3B |
Common Stock | 58K | 59K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K |
Retained Earnings | -707.25M | -683.61M | -672M | -666.3M | -649.5M | -584.3M | -378M | 40.3M | 287.4M | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -60.4M | 0 |
Accumulated OCI | -493K | -2.9M | -1.2M | 5.5M | -2.2M | 20M | 8M | -13.2M | 13.2M | 5.6M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PODD Cash Flow Statement
Insulet Corporation (PODD) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 41.3M | 35.9M | 98.4M | 84M | -68.1M | 119M | 145.7M | 430.3M | 569.3M | 619.3M |
Operating CF Margin % | 8.91% | 6.37% | 13.33% | 9.29% | -6.2% | 9.12% | 8.59% | 20.77% | 21.02% | - |
Operating CF Growth % | 159.57% | -13.08% | 174.09% | -14.63% | -181.07% | 274.74% | 22.44% | 195.33% | 32.3% | 256.47% |
Net Income | -26.8M | 3.3M | 11.6M | 6.8M | 16.8M | 4.6M | 206.3M | 418.3M | 247.1M | 302.8M |
Depreciation & Amortization | 13.9M | 15.6M | 27.9M | 55.4M | 57.4M | 63.2M | 72.8M | 80.8M | 90.4M | 101.1M |
Stock-Based Compensation | 31.9M | 37.5M | 28.7M | 35.9M | 34.4M | 40.9M | 48.3M | 69.3M | 62.7M | 45.5M |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -1M | 500K | -136.9M | 62.2M | 69.2M |
Other Non-Cash Items | 20.6M | 32.3M | 49.9M | 49.3M | 86.9M | 13.8M | 8.4M | 15.8M | 130M | 98.6M |
Working Capital Changes | 1.7M | -52.8M | -19.7M | -63.4M | -263.6M | -2.5M | -190.6M | -17M | -23.1M | 2.1M |
Change in Receivables | -26.3M | -14.6M | -10.9M | -13.7M | -71.3M | -51.8M | -154.2M | -10.4M | -140.2M | -94.7M |
Change in Inventory | 1.7M | -38.8M | -30.2M | -50.5M | -154.4M | -49.1M | -53.6M | -32.4M | -10.6M | -38M |
Change in Payables | 27.3M | -5.4M | 25.6M | 7.1M | -15.6M | -2.4M | -11M | 2.2M | 49.2M | 84.1M |
Cash from Investing | -210.8M | -184.5M | -73.6M | 14M | -82.7M | -191.1M | -119.4M | -146.2M | -222.7M | -234.7M |
Capital Expenditures | -77.23M | -162.35M | 0 | -166.5M | -122.7M | -157.3M | -109.2M | -134M | -191.6M | -218M |
CapEx % of Revenue | 16.65% | 28.8% | 23.15% | 18.41% | 11.17% | 12.05% | 6.43% | 6.47% | 7.08% | 7.51% |
Acquisitions | 0 | 0 | 0 | 0 | 0 | -26M | -3M | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 26K | -46K | -170.9M | 0 | 0 | 0 | 0 | 0 | -31.1M | -16.7M |
Cash from Financing | 304.5M | -8.7M | 73.5M | 605.5M | 40.7M | -40.3M | -13.6M | -28.1M | -595.3M | -1.19B |
Debt Issued (Net) | 292.8M | -6.7M | 116.6M | 126.6M | 49.4M | -39.8M | -27M | -40.6M | -708.1M | -986M |
Equity Issued (Net) | 15.8M | 15.81M | -34.5M | 509.2M | 23.5M | 16.3M | 26.9M | 20.1M | -25.7M | -355.5M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -59.6M | -359.6M |
Other Financing | -4.1M | -17.82M | -8.6M | -30.3M | -32.2M | -16.8M | -13.5M | -7.6M | 138.5M | 148.5M |
Net Change in Cash | 135.4M▲ 0% | -158.7M▼ 217.2% | 99.8M▲ 162.9% | 708.3M▲ 609.7% | -115.6M▼ 116.3% | -116.7M▼ 1.0% | 14.5M▲ 112.4% | 249.2M▲ 1618.6% | -237.3M▼ 195.2% | -802.7M▲ 0% |
Free Cash Flow | -36.02M▲ 0% | -126.45M▼ 251.1% | -72.5M▲ 42.7% | -82.5M▼ 13.8% | -190.8M▼ 131.3% | -38.3M▲ 79.9% | 70.1M▲ 283.0% | 305.4M▲ 335.7% | 377.7M▲ 23.7% | 412.2M▲ 0% |
FCF Margin % | -7.77% | -22.43% | -9.82% | -9.12% | -17.36% | -2.93% | 4.13% | 14.74% | 13.95% | 14.21% |
FCF Growth % | -480.58% | -251.08% | 42.67% | -13.79% | -131.27% | 79.93% | 283.03% | 335.66% | 23.67% | 47.58% |
FCF per Share | -0.62 | -2.07 | -1.16 | -1.25 | -2.78 | -0.55 | 0.95 | 4.13 | 5.25 | 5.87 |
FCF Conversion (FCF/Net Income) | -1.54x | 10.91x | 8.48x | 12.35x | -4.05x | 25.87x | 0.71x | 1.03x | 2.30x | 1.36x |
Interest Paid | 2.5M | 0 | 0 | 2.6M | 21.5M | 34.2M | 49.9M | 0 | 0 | 0 |
Taxes Paid | 500K | 800K | 2.5M | 3M | 7M | 5.5M | 8.1M | 0 | 0 | 0 |
PODD Key Ratios
Insulet Corporation (PODD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -24.21% | 1.78% | 8.06% | 2% | 2.9% | 0.89% | 34.12% | 43.03% | 18.12% | 21.38% |
Return on Invested Capital (ROIC) | -1.56% | 3.6% | 5.11% | 4.98% | 10.36% | 2.41% | 11.72% | 14.43% | 20.13% | 24.4% |
Gross Margin | 59.76% | 65.65% | 65.06% | 64.39% | 68.45% | 61.72% | 68.35% | 69.79% | 71.63% | 71.01% |
Net Margin | -5.79% | 0.58% | 1.57% | 0.75% | 1.53% | 0.35% | 12.16% | 20.19% | 9.12% | 10.44% |
Debt / Equity | 3.57x | 2.79x | 11.94x | 1.78x | 2.31x | 3.01x | 1.98x | 1.17x | 0.69x | 0.01x |
Interest Coverage | -0.39x | 1.42x | 1.34x | 1.14x | 1.33x | 1.27x | 6.93x | 8.03x | 5.94x | 10.11x |
FCF Conversion | -1.54x | 10.91x | 8.48x | 12.35x | -4.05x | 25.87x | 0.71x | 1.03x | 2.30x | 1.36x |
Revenue Growth | 26.37% | 21.57% | 30.93% | 22.51% | 21.49% | 18.79% | 30.02% | 22.07% | 30.73% | 31.93% |
Related:PODD Dividend History·PODD Revenue History·PODD Price History·PODD P/E History·PODD Financial Ratios·PODD Institutional Holders
PODD SEC Filings & Documents
Insulet Corporation (PODD) SEC filings — annual & quarterly reports (10-K, 10-Q)
PODD Frequently Asked Questions
Insulet Corporation (PODD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Insulet Corporation (PODD) reported $2.90B in revenue for fiscal year 2025.
Insulet Corporation (PODD) grew revenue by 30.7% over the past year. This is strong growth.
Yes, Insulet Corporation (PODD) is profitable, generating $302.8M in net income for fiscal year 2025 (9.1% net margin).
Dividend & Returns
Insulet Corporation (PODD) has a return on equity (ROE) of 18.1%. This is reasonable for most industries.
Insulet Corporation (PODD) generated $412.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.